Scolaris Content Display Scolaris Content Display

Bain ou douche pré‐opératoire avec utilisation d'antiseptiques cutanés pour prévenir l'infection du site opératoire

Contraer todo Desplegar todo

Referencias

References to studies included in this review

Byrne 1992 {published data only}

Byrne DJ, Lynch W, Napier A, Davey P, Malek M, Cuschieri A. Wound infection rates: the importance of definition and post‐discharge wound surveillance. Journal of Hospital Infection 1994;26(1):37‐43.
Byrne DJ, Napier A, Cuschieri A. The value of whole body disinfection in the prevention of postoperative wound infection in clean and potentially contaminated surgery. A prospective, randomised, double‐blind, placebo‐controlled clinical trial. Surgical Research Communications 1992;12(1):43‐52.
Lynch W, Davey PG, Malek M, Byrne DJ, Napier A. Cost‐effectiveness analysis of the use of chlorhexidine detergent in preoperative whole‐body disinfection in wound infection prophylaxis. Journal of Hospital Infection 1992;21(3):179‐91.

Earnshaw 1989 {published data only}

Earnshaw JJ, Berridge DC, Slack RC, Makin GS, Hopkinson BR. Do preoperative chlorhexidine baths reduce the risk of infection after vascular reconstruction?. European Journal of Vascular Surgery 1989;3(4):323‐6.

Hayek 1987 {published data only}

Hayek LJ, Emerson JM. Preoperative whole body disinfection‐‐a controlled clinical study. Journal of Hospital Infection 1988;11(supplement B):15‐9.
Hayek LJ, Emerson JM, Gardner AM. A placebo‐controlled trial of the effect of two preoperative baths or showers with chlorhexidine detergent on postoperative wound infection rates. Journal of Hospital Infection 1987;10(2):165‐72.

Randall 1983 {published and unpublished data}

Randall PE, Ganguli L, Marcuson RW. Wound infection following vasectomy. British Journal of Urology 1983;55(5):564‐7.

Rotter 1988 {published data only}

Rotter ML, Larsen SO, Cooke EM, Dankert J, Daschner F, Greco D, et al. A comparison of the effects of preoperative whole‐body bathing with detergent alone and with detergent containing chlorhexidine gluconate on the frequency of wound infections after clean surgery. The European Working Party on Control of Hospital Infections. Journal of Hospital Infection 1988;11(4):310‐20.

Veiga 2009 {published data only}

Veiga DF, Damasceno CA, Veiga‐Filho J, Figueiras RG, Vieira RB, Garcia ES, et al. Randomized controlled trial of the effectiveness of chlorhexidine showers before elective plastic surgical procedures. Infection Control and Hospital Epidemiology 2009;30(1):77‐9.

Wihlborg 1987 {published and unpublished data}

Wihlborg O. The effect of washing with chlorhexidine soap on wound infection rate in general surgery. A controlled clinical study. Annales Chirurgiae et Gynaecologiae 1987;76(5):263‐5.

References to studies excluded from this review

Ayliffe 1983 {published data only}

Ayliffe GA, Noy MF, Babb JR, Davies JG, Jackson J. A comparison of pre‐operative bathing with chlorhexidine‐detergent and non‐medicated soap in the prevention of wound infection. Journal of Hospital Infection 1983;4(3):237‐44.

Bergman 1979 {published data only}

Bergman BR, Seeberg S. A bacteriological evaluation of a programme for preoperative total body‐washing with chlorhexidine gluconate performed by patients undergoing orthopaedic surgery. Archives of Orthopedic Trauma Surgery 1979;95(1):59‐62.

Bode 2010 {published data only}

Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke‐Grauls CM, Roosendaal R, et al. Preventing surgical‐site infections in nasal carriers of Staphylococcus aureus. New England Journal of Medicine 2010;362(1):9‐17.

Brandberg 1980 {published data only}

Brandberg A, Holm J, Hammarsten J, Schersten T. Post‐operative wound infections in vascular surgery ‐ effect of pre‐operative whole body disinfection by shower‐bath with chlorhexidine soap. Royal Society of Medicine International Congress an Symposium Series 1980;23:71‐5.

Colling 2014 {published data only}

Colling K, Statz C, Glover J, Banton K, Beilman G. Pre‐operative antiseptic shower and bath policy decreases the rate of S. aureus and methicillin‐resistant S. aureus surgical site infections in patients undergoing joint arthroplasty. Surgical Infections 2014;Nov 18. [Epub ahead of print]:1‐9.

Edminson 2010 {published data only}

Edmiston CE, Okoli O, Graham MB, Sinski S, Seabrook GR. Evidence for using chlorhexidine gluconate preoperative cleansing to reduce the risk of surgical site infection. AORN Journal 2010;92:509‐18.

Edmiston 2008 {published data only}

Edmiston CE, Krepel CJ, Seabrook GR, Lewis BD, Brown KR, Towne JB. Preoperative shower revisited: can high topical antiseptic levels be achieved on the skin surface before surgical admission?. Journal of the American College of Surgeons 2008;207(2):233‐9.

Eiselt 2009 {published data only}

Eiselt D. Presurgical skin preparation with a novel 2% chlorhexidine gluconate cloth reduces rates of surgical site infection in orthopaedic surgical patients. Orthopaedic Nursing 2009;28(3):141‐5.

Enjabert 1984 {published data only}

Enjalbert L, Levade Y, Marchetti P. Comparison of 2 antiseptic soaps used for preoperative showers. Pathologie‐biologie (Paris) 1984;32:604‐6.

Garabaldi 1988 {published data only}

Garibaldi RA, Skolnick D, Lerer T, Poirot A, Graham J, Krisuinas E, et al. The impact of preoperative skin disinfection on preventing intraoperative wound contamination. Infection Control and Hospital Epidemiology 1988;9(3):109‐13.

Jakobsson 2010 {published data only}

Jakobsson J, Perlkvist A, Wann‐Hansson C. Searching for evidence regarding using preoperative disinfection showers to prevent surgical site infections: a systematic review. World Views on Evidence‐Based Nursing 2010;Sep 28. doi: 10.1111/j.1741‐6787.2010.00201:1‐10.

Kaiser 1988 {published data only}

Kaiser AB, Kernodle DS, Barg NL, Petracek MR. Influence of preoperative showers on staphylococcal skin colonization: a comparative trial of antiseptic skin cleansers. Annals of Thoracic Surgery 1988;45:35‐8.

Kalanter‐Hormozi 2005 {published data only}

Kalantar‐Hormozi AJ, Davami B. No need for preoperative antiseptics in elective outpatient plastic surgical operations: a prospective study. Plastic and Reconstructive Surgery 2005;116(2):529‐31.

Leigh 1983 {published data only}

Leigh DA, Stronge JL, Marriner J, Sedgwick J. Total body bathing with 'Hibiscrub' (chlorhexidine) in surgical patients: a controlled trial. Journal of Hospital Infection 1983;4(3):229‐35.

Murray 2011 {published data only}

Murray MR, Saltzman MD, Gryzlo SM, Terry MA, Woodward CC, Nuber GW. Efficacy of preoperative home use of 2% chlorhexidine gluconate cloth before shoulder surgery. Journal of Shoulder and Elbow Surgery 2011;20:928‐33.

Newsom 1988 {published data only}

Newsom SW, Rowland C. Studies on perioperative skin flora. Journal of Hospital Infection 1988;11(Supplement B):21‐6.

Paulson 1993 {published data only}

Paulson DS. Efficacy evaluation of a 4% chlorhexidine gluconate as a full‐body shower wash. American Journal of Infection Control 1993;21:205‐9.

Tanner 2011 {published data only}

Tanner J, Gould D, Jenkins P, Hilliam R, Mistry N, Walsh S. A fresh look at preoperative body washing. Journal of Infection Prevention 2011;13:11‐5.

Veiga 2008 {published data only}

Veiga DF, Damasceno CAV, Filho JV, Silva RV, Cordeiro DL, Vieira AM, et al. Influence of povidone‐iodine preoperative showers on skin colonization in elective plastic surgery procedures. Reconstructive and Plastic Surgery 2008;121(1):115‐8.

Wells 1983 {published data only}

Wells FC, Newsom SW, Rowlands C. Wound infection in cardiothoracic surgery. Lancet 1983;1(8335):1209‐10.

Beaudounin 2004

Beaudouin E, Kanny G, Morisset M, Renaudin JM, Mertes M, Laxenaire MC, et al. Immediate hypersensitivity to chlorhexidine: literature review. Allergie et Immunologie (Paris) 2004;36:123‐6.

Brady 1990

Brady LM, Thomson M, Palmer MA, Harkness JL. Successful control of MRSA in a cardiothoracic surgical unit. Medical Journal of Australia 1990;152:240‐5.

Chlebicki 2013

Chlebicki MP, Safdar N, O'Horo JC, Maki DG. Preoperative chlorhexidine shower or bath for prevention of surgical site infection: a meta‐analysis. American Journal of Infection Control 2013;41:167‐73.

Cruse 1980

Cruse PJ, Foord R. The epidemiology of wound infection. A 10‐year prospective study of 62,939 wounds. Surgical Clinics of North America 1980;60(1):27‐40.

Derde 2012

Derde LP, Dautzenberg MJ, Bonten MJ. Chlorhexidine body washing to control antimicrobial‐resistant bacteria in intensive care units: a systematic review. Intensive Care Medicine 2012;38:931‐9.

Higgins 2002

Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21:539‐58.

Higgins 2011

Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies.. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. Chichester: Wiley and Sons Ltd.

Jenks 2014

Jenks PJ, Laurent M, McQuarry S, Watkins R. Clinical and economic burden of surgical site infection (SSI) and predicted financial consequences of elimination of SSI from an English hospital. Journal of Hospital Infection 2014;86:24‐33.

Kamel 2012

Kamel C, McGahan L, Polisina J, Miezwinski‐Urban M, Embil JM. Preoperative skin antiseptic preparations for preventing surgical site infections: A systematic review. Infection Control and Hospital Epidemiology 2012;33:608‐17.

Kirkland 1999

Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical‐site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infection Control and Hospital Epidemiology 1999;20(11):725‐30.

Koburger 2010

Koburger T, Hübner NO, Braun M, Siebert J, Kramer A. Standardized comparison of antiseptic efficacy of triclosan, PVP‐iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. Journal of Antimicrobial Chemotherapy 2010;65:1712‐9.

Krautheim 2004

Krautheim AB, Jermann TH, Bircher AJ. Chlorhexidine anaphylaxis: case report and review of the literature. Contact Dermatitis 2004;50:113‐6.

Lefebrve 2011

Lefebvre C, Manheimer E, Glanville J, on behalf of the Cochrane Information Retrieval Methods Group. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Mangram 1999

Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infection Control and Hospital Epidemiology 1999;20:250‐78.

Mollison 2000

Mollison J, Simpson JA, Campbell MK, Grimshaw JM. Comparison of analytical methods for cluster randomised trials: an example from a primary care setting. Journal of Epidemiology and Biostatistics 2000;5:339‐48.

Rosenthal 2013

Rosenthal VD, Richtmann R, Singh S, Apisarnthanarak A, Kübler A, Viet‐Hung N, Ramírez‐Wong FM, Portillo‐Gallo JH, Toscani J, Gikas A, Dueñas L, El‐Kholy A, Ghazal S, Fisher D, Mitrev Z, Gamar‐Elanbya MO, Kanj SS, Arreza‐Galapia Y, Leblebicioglu H, Hlinková S, Memon BA, Guanche‐Garcell H, Gurskis V, Alvarez‐Moreno C, Barkat A, Mejía N, Rojas‐Bonilla M, Ristic G, Raka L, Yuet‐Meng C. Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005‐2010. Infection Control and Hospital Epidemiology 2013;34:597‐604.

Rubinstein 1999

Rubinstein E. Infectious diseases and litigation. Journal of Hospital Infection 1999;43:Suppl:S165‐7.

Schunermann 2011

Schunemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. Chichester: John Wiley & Sons.

SIGN 2008

Scottish Intercollegiate Guidelines Network (SIGN). Search filters. Available from http://www.sign.ac.uk/methodology/filters.html#random2011.

Smyth 2008

Smyth ETM, McIlvenny G, Enstone JE, Emmerson AM, Humphreys H, Fitzpatrick F, Davies E. Newcombe RG. Spencer RC. Four Country Healthcare Associated Infection Prevalence Survey 2006: overview of the results. Journal of Hospital Infection 2008;69:230‐48.

Thomas 2000

Thomas L, Maillard JY, Lambert RJ, Russell AD. Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a "residual" concentration. Journal of Hospital Infection 2000;46:297‐304.

Wilcox 2003

Wilcox MH, Hall J, Pike H, Templeton PA, Fawley WN, Parnell P, et al. Use of perioperative mupirocin to prevent methicillin‐resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. Journal of Hospital Infection 2003;54:196‐201.

Wilson 1986

Wilson APR, Treasure T, Sturridge MF, Gruneberg RN. A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis. Lancet 1986;February:311‐2.

References to other published versions of this review

Webster 2006

Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD004985.pub3]

Webster 2007

Webster J, Osborne S. Systematic review and meta‐analysis of the use of antiseptics for pre‐operative showering to prevent surgical site infection. British Journal of Surgery 2006;93:1335‐41.

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Byrne 1992

Methods

RCT.
Power calculation: yes.
Follow‐up period: 6 weeks after discharge.

Participants

3733 patients undergoing elective or potentially contaminated surgery.
Exclusion criteria: patients undergoing day surgery, emergency surgery, re‐operation or contaminated surgery and those unable to comply with the washing procedure, or with a known allergy to chlorhexidine or having more than the standard prophylactic antibiotic regimen.
Baseline comparability: age, sex, type of surgery, ASEPSIS score.

Interventions

All patients showered 3 times (on admission, the night before surgery and the morning of surgery) using 50 ml of either:
Group 1: 4% chlorhexidine, or
Group 2: a placebo.
Written instructions were provided to all participants.

Outcomes

Primary outcome:
Wound infection was defined as discharge of pus from a wound for inpatients or outpatients, or an ASEPSIS score greater than 10.
Group 1: 256/1754 (14.6%);
Group 2: 272/1735 (15.7%).
Secondary outcomes:
Death, allergic reactions, cost.

Notes

Data were extracted from 3 papers reporting results from 1 study (see Lynch 1992 & Byrne 1994). There were minor discrepancies in numbers reported between the 3 studies. The version reported is the definitive study (personal correspondence with author). The abstract stated there were 1753 patients in the placebo group but this should have been 1735

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Randomisation was performed in blocks of 6. Randomisation in each group of 6 was by computer‐generated random numbers.

Allocation concealment (selection bias)

Low risk

Personal communication with author. Allocation in sealed envelopes.

Blinding (performance bias and detection bias)
Investigator and participant

Low risk

2 bottles of either 4% chlorhexidine detergent solution or a physically‐identical placebo detergent were given to the patient. Neither the investigators nor the patient were aware of the allocation.
Outcome blinding was not specifically mentioned, however, it seems likely that those assessing infection status would have been unaware of the allocation.

Blinding (performance bias and detection bias)
Outcome assessor

Low risk

Outcome assessment blinded

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Of 3733 patients randomised, 244 (6.5%) were excluded from the outcome analysis. The majority of these, 219 (5.9%) were because the operation was cancelled after randomisation. 4 patients in the chlorhexidine group and 9 patients in the control group were excluded for protocol violations. However, as these numbers are extremely small (0.4% of those randomised), it is unlikely that results were compromised.

Selective reporting (reporting bias)

Low risk

The study reported on all of the stated outcomes.

Other bias

Low risk

The trial was supported by ICI Pharmaceuticals. However, as results did not support the use of chlorhexidine, it is unlikely that results were compromised.

Earnshaw 1989

Methods

RCT.
Power calculation: no.
Follow‐up period: until hospital discharge.

Participants

66 patients undergoing vascular reconstruction surgery.
Exclusion: none reported.
Baseline comparability: stated that groups were similar, no data.

Interventions

All patients had 2 baths.
Group 1: painted entire body with undiluted 4% chlorhexidine followed by rinsing in the bath. Precise instructions given;
Group 2: non‐medicated soap used. No specific instructions provided.

Outcomes

Primary outcome:
Wound infection was defined as discharge of pus from a wound; 1 patient with severe cellulitis was also included.
Group 1: 8/31 (26%);
Group 2: 4/35, (11.4%).
Secondary outcome:
Death.

Notes

Different washing information provided to participants in each group.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not described. Investigator contacted ‐ no further information available.

Allocation concealment (selection bias)

Unclear risk

Not described. Investigator contacted ‐ no further information available.

Blinding (performance bias and detection bias)
Investigator and participant

High risk

Both the investigator and the participant were aware of the allocation.
Postoperatively wounds were reviewed blind until patients left hospital.

Blinding (performance bias and detection bias)
Outcome assessor

Low risk

Outcome assessment blinded.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Results were available for all those enrolled. No drop outs or exclusions were described.

Selective reporting (reporting bias)

Low risk

The study reported on wound infection. A number of post hoc analyses were also conducted.

Other bias

High risk

Baseline data tables were not provided but the author stated that "clinical details of the two groups were similar".
Different washing information provided to participants in each group.
Hibiscrub (chlorhexidine) was provided by ICI. However, as results favoured the use of soap, it is unlikely that the involvement of the pharmaceutical company influenced results.

Hayek 1987

Methods

Cluster RCT.
Power calculation: no.
Follow‐up period: until hospital discharge.

Participants

2015 patients undergoing routine surgery.
Exclusion: those receiving antibiotics or with an existing infection.
Baseline comparability: age, sex, preoperative skin preparation, wound classification, proportion who washed their hair.

Interventions

All patients had either a shower or bath on the day before and morning of their operation.
Group 1: chlorhexidine 4%. Instruction card for washing provided.
Group 2: placebo. Instruction card for washing provided (5 months into the study, the placebo was found to have antimicrobial properties and was changed).
Group 3: bar soap. No washing instructions provided.

Outcomes

Primary outcome:
Wound infection was defined as either discharge of pus from a wound, or erythema, or swelling considered to be greater than expected.
Group 1: 62/689 (9.0%);
Group 2: 83/700 (11.7%);
Group 3: 80/626 (12.8%).

Notes

Data were extracted from 2 papers reporting results from 1 study (Hayek 1988).

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not described.

Allocation concealment (selection bias)

Unclear risk

Not described.

Blinding (performance bias and detection bias)
Investigator and participant

High risk

3 arms to the study. "None of the ward staff or those assessing the wounds were aware of whether placebo or active compound was being used as these were issued in identical coded sachets, though no form of double blind was possible for the bar soap group".

Blinding (performance bias and detection bias)
Outcome assessor

Low risk

Outcome assessment blinded.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

It appears from the text that results were available from all patients who entered the study. However, as patients were followed up for 6 weeks postoperatively; it seems unusual that none were lost to follow‐up.

Selective reporting (reporting bias)

Low risk

All data reported.

Other bias

High risk

No baseline data presented. The authors state that "The three groups are comparable except for one interesting facet; only 14% washed their hair with bar soap against 28% with either of the liquids.
Specific washing instructions were provided to the chlorhexidine and placebo groups but not to the bar soap group.
5 months into the study, the placebo was found to have antimicrobial properties and was changed.
It is unclear how this large study was funded. No competing interests were declared.

Randall 1983

Methods

RCT.
Power calculation: no.
Follow‐up period: 1 week after discharge.

Participants

94 patients undergoing vasectomy.
Exclusion: none stated.
Baseline comparability: none stated.

Interventions

Group 1: 1 preoperative shower with chlorhexidine 4%,
Group 2: 1 shower with normal soap.
Group 3: no shower.

Outcomes

Primary outcome:
Wound infection was defined as discharging either purulent or serous fluid.
Group 1: 12/32 (37.5%);
Group 2: 10/30 (33.3%);
Group 3: 9/32 (28.1%).

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Personal correspondence with study authors confirmed that trialists used computer‐generated random numbers.

Allocation concealment (selection bias)

Unclear risk

Method not described.

Blinding (performance bias and detection bias)
Investigator and participant

High risk

Blinding of the intervention was not possible.

Blinding (performance bias and detection bias)
Outcome assessor

Unclear risk

It is unclear if outcome assessment was blinded.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

All but 1 enrolled patient were assessed 7 days postoperatively; 83 returned to the ward, 10 were contacted at home and 1 was lost to follow‐up (it is unclear which group this patient was in); results were presented for the total number enrolled.

Selective reporting (reporting bias)

Low risk

All data reported.

Other bias

Low risk

No baseline data presented.
No competing interests declared.

Rotter 1988

Methods

Cluster RCT.
Power calculation: no.
Follow‐up period: 3 weeks after discharge.

Participants

2953 patients undergoing elective clean surgery.
Exclusion: patients with a temperature of 37.5oC on the day of or day before surgery, infection remote from operation site, antibiotics given within 7 days prior to surgery for infection, incarcerated inguinal hernia, radical mastectomy.
Baseline comparability: age, sex, type of surgery, antibiotic prophylaxis, hair washed, hair removal method, wound drainage.

Interventions

All patients had 2 showers;1 the day before surgery and 1 on the day of surgery.
Group 1: used 50 ml of chlorhexidine 4% for each shower;
Group 2: placebo.
Special application instructions were provided to all participants.

Outcomes

Primary outcome:
Wound infection was defined in the report as "inflammation of the surgical wound with discharge of pus, spontaneous and/or after surgical intervention that occurs during hospitalisation or during routine follow‐up"
Group 1: 37/1413 (2.6%);
Group 2: 33/1400 (2.4%).

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Randomisation was carried out for each surgical unit by means of computer‐generated patient trial numbers.

Allocation concealment (selection bias)

Low risk

Bottles of solution were contained in boxes of 10, each holding 5 chlorhexidine and 5 placebo in random sequence. Unless the code was broken, it was impossible to know which preparation the patient had used.

Blinding (performance bias and detection bias)
Investigator and participant

Low risk

Neither patients nor investigators were aware of group allocation.

Blinding (performance bias and detection bias)
Outcome assessor

Low risk

Outcome assessment was by routine surveillance methods employed by individual hospitals (infection control nurse or surgeon). They were unaware of group allocation.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

140 (4.7%) patients were withdrawn after randomisation either because the patient was not operated on (62 patients), had had 1 bath only (26), operation not stated 'clean' (14) or had a current infection (38). The withdrawals were evenly distributed between the chlorhexidine and placebo groups.

Selective reporting (reporting bias)

Low risk

All data reported.

Other bias

Low risk

ICI supplied the bathing materials. However, as results favoured the placebo group, this is unlikely to have affected results.

Veiga 2009

Methods

RCT.
Power calculation: no.
Follow‐up period: 30 days.

Participants

Adult patients, scheduled for plastic surgery at a University‐affiliated hospital in Brazil.

Exclusions: hypersensitivity to chlorhexidine, presence of skin lesions, antibiotic use at time of surgery, diabetes, heavy smoking, immunosuppression.

Interventions

Group 1: shower with liquid‐based detergent containing 4% chlorhexidine;
Group 2: shower with the same liquid‐based detergent, without chlorhexidine;
Group 3: no preoperative showering instructions were given.
Patients in Groups 1 and 2 were asked to rinse thoroughly, lather with the antiseptic, rinse, lather and rinse again.

Outcomes

Primary outcome:
Surgical site infection (defined using Centers for Disease Control criteria for wound infection and wound classification)
Group 1: 1/50 (2%);
Group 2: 1/50 (2%);
Group 3: 0/50 (0%).

Secondary outcome:
Adverse reactions: no adverse reactions were reported.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated.

Allocation concealment (selection bias)

Unclear risk

Not described.

Blinding (performance bias and detection bias)
Investigator and participant

Low risk

Surgeons and patients were all blinded to the allocation group.

Blinding (performance bias and detection bias)
Outcome assessor

Low risk

Outcome assessors and microbiologists were all blinded to the allocation group.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

All patients were followed for the nominated 30 days.

Selective reporting (reporting bias)

Low risk

Expected outcomes were reported.

Other bias

Low risk

The placebo solution was provided by Rioquimica Industria Farmaceutica, the manufacturer of the intervention product. However, as results in different groups were similar, this is unlikely to have affected results.

Wihlborg 1987

Methods

RCT.
Power calculation: no.
Follow‐up period: until hospital discharge.

Participants

1530 patients undergoing elective surgery of the biliary tract, inguinal hernia and breast cancer.
Exclusion: none stated.
Baseline comparability: age, duration of surgery > 2 hours, steroids, diabetes, malignancy (other than breast cancer), type of surgery.

Interventions

Group 1: patients washed their entire body with chlorhexidine on the day before surgery using 2 consecutive applications followed by rinsing under the shower;
Group 2: washed only that part of the body to be submitted to surgery with chlorhexidine soap;
Group 3: No chlorhexidine wash.

Outcomes

Primary outcome:
Wound infection was defined as a definite collection of pus emptying itself spontaneously or after incision:
Group 1: 9/541 (1.7%);
Group 2: 23/552 (4.2%);
Group 3: 20/437 (4.6).

Notes

This study was conducted over a 7 year period from 1978 to 1984.
It was unclear from the text whether patients allocated to the 'no chlorhexidine wash' group had any preoperative shower. 3 patients died and were not included in the analysis.
Strength of wash solution was not stated.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Personal correspondence with study authors confirmed that they used a randomisation list.

Allocation concealment (selection bias)

Low risk

Patients were randomly allocated to 1 of 3 wards in which different preoperative preparation schedules were used. The author states that "The randomisation was done by the Chief surgeon in such a way that he did not know the identity of the patients allocated to each ward."

Blinding (performance bias and detection bias)
Investigator and participant

High risk

Blinding would have been impossible because of the allocation method.

Blinding (performance bias and detection bias)
Outcome assessor

High risk

Outcome assessment was not blinded (personal correspondence with study authors).

Incomplete outcome data (attrition bias)
All outcomes

Low risk

3 patients died in the few days following surgery, these were not identified by group.

Selective reporting (reporting bias)

Low risk

All data reported.

Other bias

Unclear risk

Baseline risk factors were similar across groups.
No competing interests declared.

Abbreviations

> = more than
ASEPSIS = a scoring method for postoperative wounds infections for use in clinical trials of antibiotic prophylaxis (Wilson 1986).
RCT = randomised controlled trial

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Ayliffe 1983

Not a randomised controlled trial.

Bergman 1979

No data on wound infection. Not a randomised controlled trial.

Bode 2010

Co‐intervention (mupirocin and chlorhexidine soap). Also included patients who did not undergo surgery.

Brandberg 1980

Not a randomised controlled trial. Local wash versus full body wash with chlorhexidine.

Colling 2014

Retrospective review comparing two hospitals. One hospital had a pre‐operative showering policy using an antiseptic solution; the other hospital did not.

Edminson 2010

Not a clinical trial.

Edmiston 2008

Healthy volunteers used to compare skin concentration levels of chlorhexidine gluconate (CHG) following washing with various CHG products.

Eiselt 2009

Not a randomised controlled trial. Used a pre and post intervention design.

Enjabert 1984

Not a randomised controlled trial.

Garabaldi 1988

No no‐antiseptic group. Did not report infection rates by group.

Jakobsson 2010

Systematic review.

Kaiser 1988

Did not report infection rates by group.

Kalanter‐Hormozi 2005

Patients in both groups showered with water. The trial compared methods of skin preparation prior to surgery.

Leigh 1983

Not a randomised controlled trial.

Murray 2011

2% chlorhexidine gluconate cloths were used to wipe over the entire body one hour after showering.

Newsom 1988

Not a randomised controlled trial. Patients were allocated by month.

Paulson 1993

Assessed reduction in microbial loads in healthy volunteers.

Tanner 2011

Trial of healthy volunteers

Veiga 2008

Assessed the influence of povidone‐iodine preoperative showers on skin colonization. Rates of wound infection not reported.

Wells 1983

Not a randomised controlled trial. Did not report infection rates by group.

Data and analyses

Open in table viewer
Comparison 1. Chlorhexidine 4% versus placebo

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Surgical site infection Show forest plot

4

7791

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.80, 1.04]

Analysis 1.1

Comparison 1 Chlorhexidine 4% versus placebo, Outcome 1 Surgical site infection.

Comparison 1 Chlorhexidine 4% versus placebo, Outcome 1 Surgical site infection.

2 Surgical site infection (high quality studies) Show forest plot

2

6302

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.82, 1.10]

Analysis 1.2

Comparison 1 Chlorhexidine 4% versus placebo, Outcome 2 Surgical site infection (high quality studies).

Comparison 1 Chlorhexidine 4% versus placebo, Outcome 2 Surgical site infection (high quality studies).

3 Allergic reaction Show forest plot

2

3589

Risk Ratio (M‐H, Fixed, 95% CI)

0.89 [0.36, 2.19]

Analysis 1.3

Comparison 1 Chlorhexidine 4% versus placebo, Outcome 3 Allergic reaction.

Comparison 1 Chlorhexidine 4% versus placebo, Outcome 3 Allergic reaction.

Open in table viewer
Comparison 2. Chlorhexidine 4% versus bar soap

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Surgical site infection Show forest plot

3

1443

Risk Ratio (M‐H, Random, 95% CI)

1.02 [0.57, 1.84]

Analysis 2.1

Comparison 2 Chlorhexidine 4% versus bar soap, Outcome 1 Surgical site infection.

Comparison 2 Chlorhexidine 4% versus bar soap, Outcome 1 Surgical site infection.

Open in table viewer
Comparison 3. Chlorhexadine 4% versus no wash

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Surgical site infection Show forest plot

3

1142

Risk Ratio (M‐H, Random, 95% CI)

0.82 [0.26, 2.62]

Analysis 3.1

Comparison 3 Chlorhexadine 4% versus no wash, Outcome 1 Surgical site infection.

Comparison 3 Chlorhexadine 4% versus no wash, Outcome 1 Surgical site infection.

Open in table viewer
Comparison 4. Chlorhexidine full wash versus partial wash

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Surgical site infection Show forest plot

1

1093

Risk Ratio (M‐H, Fixed, 95% CI)

0.40 [0.19, 0.85]

Analysis 4.1

Comparison 4 Chlorhexidine full wash versus partial wash, Outcome 1 Surgical site infection.

Comparison 4 Chlorhexidine full wash versus partial wash, Outcome 1 Surgical site infection.

Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
Figuras y tablas -
Figure 1

Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
Figuras y tablas -
Figure 2

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.

Comparison 1 Chlorhexidine 4% versus placebo, Outcome 1 Surgical site infection.
Figuras y tablas -
Analysis 1.1

Comparison 1 Chlorhexidine 4% versus placebo, Outcome 1 Surgical site infection.

Comparison 1 Chlorhexidine 4% versus placebo, Outcome 2 Surgical site infection (high quality studies).
Figuras y tablas -
Analysis 1.2

Comparison 1 Chlorhexidine 4% versus placebo, Outcome 2 Surgical site infection (high quality studies).

Comparison 1 Chlorhexidine 4% versus placebo, Outcome 3 Allergic reaction.
Figuras y tablas -
Analysis 1.3

Comparison 1 Chlorhexidine 4% versus placebo, Outcome 3 Allergic reaction.

Comparison 2 Chlorhexidine 4% versus bar soap, Outcome 1 Surgical site infection.
Figuras y tablas -
Analysis 2.1

Comparison 2 Chlorhexidine 4% versus bar soap, Outcome 1 Surgical site infection.

Comparison 3 Chlorhexadine 4% versus no wash, Outcome 1 Surgical site infection.
Figuras y tablas -
Analysis 3.1

Comparison 3 Chlorhexadine 4% versus no wash, Outcome 1 Surgical site infection.

Comparison 4 Chlorhexidine full wash versus partial wash, Outcome 1 Surgical site infection.
Figuras y tablas -
Analysis 4.1

Comparison 4 Chlorhexidine full wash versus partial wash, Outcome 1 Surgical site infection.

Summary of findings for the main comparison. Preoperative showering with chlorhexidine 4% compared to placebo

pre‐operative showering with Chlorhexidine 4% compared to placebo for surgical patients

Patient or population: surgical patients

Settings: Hospitals

Intervention: pre‐operative showering with Chlorhexidine 4%

Comparison: placebo

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

placebo

pre‐operative showering with Chlorhexidine 4%

Surgical site infection
Follow‐up: 1 ‐ 6 weeks1

Low risk population

RR 0.91
(0.8 to 1.04)

7791
(4 studies)

⊕⊕⊕⊕
high2

30 per 1000

27 per 1000
(24 to 31)

High risk population

100 per 1000

91 per 1000
(80 to 104)

Allergic reaction
Follow‐up: 1 ‐ 6 weeks1

Study population

RR 0.89
(0.36 to 2.19)

3589
(2 studies)

⊕⊕⊕⊝
moderate3

6 per 1000

5 per 1000
(2 to 13)

Medium risk population

3 per 1000

3 per 1000
(1 to 7)

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Some studies followed patients only until hospital discharge; however, as these studies are over 20 years old, we have assumed 7 days.
2 In one trial, five months into the study, the placebo solution was found to contain a microbiological agent. The solution was changed for the remaining 17 months of the trial. There was a total of over 7,000 participants included in this outcome, so we do not believe that the overall effect estimate would have been substantially altered.
3 Only 19 events were reported. All of these were from one trial.

Figuras y tablas -
Summary of findings for the main comparison. Preoperative showering with chlorhexidine 4% compared to placebo
Summary of findings 2. Chlorhexidine 4% compared with bar soap

Chlorhexidine 4% compared to bar soap for Surgical patients

Patient or population: Surgical patients

Settings:

Intervention: Chlorhexidine 4%

Comparison: bar soap

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

bar soap

Chlorhexidine 4%

Surgical site infection

Study population

RR 1.02
(0.57 to 1.84)

1443
(3 studies)

⊕⊝⊝⊝
very low1,2,3

136 per 1000

139 per 1000
(78 to 250)

Medium risk population

128 per 1000

131 per 1000
(73 to 236)

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 The method of allocation was unclear in some studies and outcome assessment was not blinded.
2 Heterogeneity between trials was evident; this was most probably due to the different types of surgeries and different definitions used for infection.
3 95% confidence interval around the pooled estimate of effect includes both 1) no effect and 2) appreciable benefit or appreciable harm.

Figuras y tablas -
Summary of findings 2. Chlorhexidine 4% compared with bar soap
Summary of findings 3. Chlorhexadine 4% compared with no wash

Chlorhexadine 4% compared to no wash for surgical patients

Patient or population: surgical patients

Settings: Hospital

Intervention: Chlorhexadine 4%

Comparison: no wash

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

no wash

Chlorhexadine 4%

Surgical site infection
Follow‐up: 1 ‐ 3 weeks1

Study population

RR 0.82
(0.26 to 2.62)

1142
(3 studies)

⊕⊝⊝⊝
very low2,3,4

56 per 1000

46 per 1000
(15 to 147)

Medium risk population

46 per 1000

38 per 1000
(12 to 121)

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Some studies followed patients only until hospital discharge; as the studies were over 20 years old, we have assumed this to be one week.
2 A number of potential biases existed including inadequate allocation concealment and blinding.
3 Hetrogeneity between studies was evident; this was most likely due to different types of surgeries, differences in length of follow‐up, varying sample sizes and ways of defining infection.
4 Wide confidence intervals, low event rate.

Figuras y tablas -
Summary of findings 3. Chlorhexadine 4% compared with no wash
Comparison 1. Chlorhexidine 4% versus placebo

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Surgical site infection Show forest plot

4

7791

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.80, 1.04]

2 Surgical site infection (high quality studies) Show forest plot

2

6302

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.82, 1.10]

3 Allergic reaction Show forest plot

2

3589

Risk Ratio (M‐H, Fixed, 95% CI)

0.89 [0.36, 2.19]

Figuras y tablas -
Comparison 1. Chlorhexidine 4% versus placebo
Comparison 2. Chlorhexidine 4% versus bar soap

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Surgical site infection Show forest plot

3

1443

Risk Ratio (M‐H, Random, 95% CI)

1.02 [0.57, 1.84]

Figuras y tablas -
Comparison 2. Chlorhexidine 4% versus bar soap
Comparison 3. Chlorhexadine 4% versus no wash

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Surgical site infection Show forest plot

3

1142

Risk Ratio (M‐H, Random, 95% CI)

0.82 [0.26, 2.62]

Figuras y tablas -
Comparison 3. Chlorhexadine 4% versus no wash
Comparison 4. Chlorhexidine full wash versus partial wash

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Surgical site infection Show forest plot

1

1093

Risk Ratio (M‐H, Fixed, 95% CI)

0.40 [0.19, 0.85]

Figuras y tablas -
Comparison 4. Chlorhexidine full wash versus partial wash